This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buckland, M. S.
Right arrow Articles by Longhurst, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buckland, M. S.
Right arrow Articles by Longhurst, H. J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, November 2005, p. 1328-1330, Vol. 12, No. 11
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.11.1328-1330.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Serological Markers (Anti-Saccharomyces cerevisiae Mannan Antibodies and Antineutrophil Cytoplasmic Antibodies) in Inflammatory Bowel Disease: Diagnostic Utility and Phenotypic Correlation

M. S. Buckland,1* M. Mylonaki,2 D. Rampton,2 and H. J. Longhurst1

Department of Clinical Immunology, St. Bartholomew's, London, United Kingdom,1 Department of Adult and Paediatric Gastroenterology, Barts, and The London School of Medicine and Dentistry, London, United Kingdom2

Received 4 August 2005/ Returned for modification 6 September 2005/ Accepted 8 September 2005

We have evaluated the utility of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies for distinguishing Crohn's disease from ulcerative colitis and other diarrheal illnesses by evaluating sera from 396 patients. Sensitivity, specificity, and phenotypic correlations were investigated. The implications of our findings for implementing these tests in routine clinical testing are discussed.


* Corresponding author. Mailing address: Department of Clinical Immunology, 1st Floor, 51-53 Barts Close, W. Smithfield, St. Bartholomew's, London EC1A 7BE, United Kingdom. Phone: 44 207 601 8229. Fax: 44 207 601 7031. E-mail: matthew.buckland{at}bartsandthelondon.nhs.uk.


Clinical and Diagnostic Laboratory Immunology, November 2005, p. 1328-1330, Vol. 12, No. 11
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.11.1328-1330.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.